345 related articles for article (PubMed ID: 15496142)
1. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR
Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
Arnesen T; Betts MJ; Pendino F; Liberles DA; Anderson D; Caro J; Kong X; Varhaug JE; Lillehaug JR
BMC Biochem; 2006 Apr; 7():13. PubMed ID: 16638120
[TBL] [Abstract][Full Text] [Related]
3. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.
Arnesen T; Gromyko D; Horvli O; Fluge Ø; Lillehaug J; Varhaug JE
Thyroid; 2005 Oct; 15(10):1131-6. PubMed ID: 16279846
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex.
Arnesen T; Gromyko D; Pendino F; Ryningen A; Varhaug JE; Lillehaug JR
Oncogene; 2006 Jul; 25(31):4350-60. PubMed ID: 16518407
[TBL] [Abstract][Full Text] [Related]
5. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ
FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
[TBL] [Abstract][Full Text] [Related]
7. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).
Arnesen T; Gromyko D; Kagabo D; Betts MJ; Starheim KK; Varhaug JE; Anderson D; Lillehaug JR
BMC Biochem; 2009 May; 10():15. PubMed ID: 19480662
[TBL] [Abstract][Full Text] [Related]
8. The protein acetyltransferase ARD1: a novel cancer drug target?
Arnesen T; Thompson PR; Varhaug JE; Lillehaug JR
Curr Cancer Drug Targets; 2008 Nov; 8(7):545-53. PubMed ID: 18991565
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ARD1 variants in mammalian cells.
Kim SH; Park JA; Kim JH; Lee JW; Seo JH; Jung BK; Chun KH; Jeong JW; Bae MK; Kim KW
Biochem Biophys Res Commun; 2006 Feb; 340(2):422-7. PubMed ID: 16376303
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of hNAT5/hSAN: an evolutionarily conserved component of the NatA protein N-alpha-acetyltransferase complex.
Arnesen T; Anderson D; Torsvik J; Halseth HB; Varhaug JE; Lillehaug JR
Gene; 2006 Apr; 371(2):291-5. PubMed ID: 16507339
[TBL] [Abstract][Full Text] [Related]
11. Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.
Arnesen T; Kong X; Evjenth R; Gromyko D; Varhaug JE; Lin Z; Sang N; Caro J; Lillehaug JR
FEBS Lett; 2005 Nov; 579(28):6428-32. PubMed ID: 16288748
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin.
Lim JH; Chun YS; Park JW
Cancer Res; 2008 Jul; 68(13):5177-84. PubMed ID: 18593917
[TBL] [Abstract][Full Text] [Related]
13. Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase.
Van Damme P; Evjenth R; Foyn H; Demeyer K; De Bock PJ; Lillehaug JR; Vandekerckhove J; Arnesen T; Gevaert K
Mol Cell Proteomics; 2011 May; 10(5):M110.004580. PubMed ID: 21383206
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of splicing, localization and stability of mammalian ARD1235 and ARD1225 isoforms.
Chun KH; Cho SJ; Choi JS; Kim SH; Kim KW; Lee SK
Biochem Biophys Res Commun; 2007 Feb; 353(1):18-25. PubMed ID: 17161380
[TBL] [Abstract][Full Text] [Related]
15. The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides.
Gautschi M; Just S; Mun A; Ross S; Rücknagel P; Dubaquié Y; Ehrenhofer-Murray A; Rospert S
Mol Cell Biol; 2003 Oct; 23(20):7403-14. PubMed ID: 14517307
[TBL] [Abstract][Full Text] [Related]
16. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
Lim JH; Park JW; Chun YS
Cancer Res; 2006 Nov; 66(22):10677-82. PubMed ID: 17108104
[TBL] [Abstract][Full Text] [Related]
17. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.
Sánchez-Puig N; Fersht AR
Protein Sci; 2006 Aug; 15(8):1968-76. PubMed ID: 16823041
[TBL] [Abstract][Full Text] [Related]
19. The chaperone-like protein HYPK acts together with NatA in cotranslational N-terminal acetylation and prevention of Huntingtin aggregation.
Arnesen T; Starheim KK; Van Damme P; Evjenth R; Dinh H; Betts MJ; Ryningen A; Vandekerckhove J; Gevaert K; Anderson D
Mol Cell Biol; 2010 Apr; 30(8):1898-909. PubMed ID: 20154145
[TBL] [Abstract][Full Text] [Related]
20. Different subcellular localizations and functions of human ARD1 variants.
Seo JH; Park JH; Lee EJ; Kim KW
Int J Oncol; 2015 Feb; 46(2):701-7. PubMed ID: 25421966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
